ActiGraft® is an autologous blood clot product
CLAIMED FEATURES: ActiGraft® is an FDA-cleared regenerative wound care solution that enables health care providers to produce—in real time—in vitro blood clots from a patient’s whole blood. Once applied, the blood clot tissue serves as a protective covering, biologic scaffold and wound microenvironment to promote the natural wound healing processes of the body.
INTENDED USE: ActiGraft is topically applied for the management of exuding cutaneous wounds, such as leg ulcers, pressure ulcers, diabetic ulcers, and mechanically or surgically-debrided wounds.
Clot size: 6sq cm
If you have Medicare Part B coverage, you can purchase this product at a store that accepts Medicare. You need a written order prescribed by a physician enrolled in Medicare. You will need to pay deductibles and/or co-payment. The actual copayment amount can vary by your state. The table below illustrates the highest (ceiling) and lowest (floor) expected co-payment across the country.
If your insurance does not cover this product, you can purchase it directly from any store. A list of online stores and prices is provided below for your convenience. For updated prices, find it on the internet at https://woundreference.com/app/product?id=2461
This handout will be emailed to specified recipients (separate addresses with comma).
Generate a customized product handout for your patient
Sorry, this content is only available to PRO and PRO+HBO members. Please upgrade for access to product handouts.